Acumen Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.85-$3.60 |
Market Cap | $178.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $329,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$104.8M |
Diluted EPS | -$2 |
News
See moreYahoo Finance • 19 days ago
Acumen targets ALTITUDE-AD Phase II readout in late 2026 while advancing EBD program with $36M funding
Yahoo Finance • 20 days ago
Pre-Market Earnings Report for March 26, 2026 : CMC, DOO, SCVL, DBI, LOVE, LUCD, ABOS, CGTX, RMTI
Yahoo Finance • 30 days ago
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
Yahoo Finance • last month
Acumen Pharmaceuticals to Participate in the Stifel 2026 Virtual CNS Forum
About
CEO | Mr. Daniel J. O'Connell M.B.A. |
CFO | Mr. Matt Zuga |
Address | 1210-1220 Washington St., Newton, MA, United States, 02465 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 60 |
